Research Design Service: West Midlands
« back

Action Medical Research and LifeArc: Translational funding

  Wednesday, 14 Jun 2023 | Funding Deadline

Action Medical Research and LifeArc want to improve the lives of children suffering from rare disease and are working together to co-fund translational, rare disease research projects. Co-funding aims to accelerate promising, cutting-edge medical research that could have a significant impact on the treatment of infants, children and young people (CYP) with any of the >7000 heterogeneous conditions collectively called ‘rare disease’.

A high proportion of paediatric rare diseases are monogenic and poorly served by more traditional treatment options. Many of these conditions may benefit from newer gene therapy approaches. Eligible applications could therefore include projects focused on the development of targeted gene therapy.  All modalities of intervention are eligible for support from the scheme, including small molecules, peptides, antibodies, cell and gene therapy, vaccines, diagnostic or prognostic approaches (such as biomarker identification and/or validation, improved imaging or screening techniques), medical devices, and psychological interventions.

Deadline for proposals: 14 June 2023
Find out more here